BackCuranex PharmaceuticalsCommon Stock Overview

Curanex PharmaceuticalsCommon Stock Receivables

Latest receivables for CURX: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Curanex PharmaceuticalsCommon Stock Receivables History

Loading

Curanex PharmaceuticalsCommon Stock vs. peers: Receivables Comparison

Loading

Curanex PharmaceuticalsCommon Stock Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Curanex PharmaceuticalsCommon Stock (CURX) FAQ

Curanex PharmaceuticalsCommon Stock (CURX) currently reports a receivables of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Curanex PharmaceuticalsCommon Stock's receivables history and peer comparisons.

Curanex PharmaceuticalsCommon Stock's receivables changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Curanex PharmaceuticalsCommon Stock reported $0 in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Curanex PharmaceuticalsCommon Stock, and consider following CURX for alerts when major investors trade the stock.

Curanex PharmaceuticalsCommon Stock is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CURX with unrelated industries.